What are you looking for today?

Butler, Kevin, Chenoweth, M, El-Boraie, A, Giratallah, H, Kowalczyk, W, Heishman, S, Tyndale, RF and Le Foll, B (2021) Impact of CYP2A6 Activity on Nicotine Reinforcement and Cue Reactivity in Daily Smokers. Nicotine & Tobacco Research, 23 (10). pp. 1735-1743. ISSN 1469-994X

Document

Abstract

Abstract

Introduction: Variation in CYP2A6, the primary enzyme responsible for nicotine metabolism, is associated with nicotine dependence, cigarette consumption, and abstinence outcomes in smokers. The impact of CYP2A6 activity on nicotine reinforcement and tobacco cue-reactivity, mechanisms that may contribute to these previous associations, has not been fully evaluated.
Aims and Methods: CYP2A6 activity was indexed using 3 genetic approaches in 104 daily smokers completing forced choice and cue-induced craving tasks assessing nicotine reinforcement and tobacco cue-reactivity, respectively. First, smokers were stratified by the presence or absence of reduced/loss-of-function CYP2A6 gene variants (normal vs. reduced metabolizers). As nicotine metabolite ratio (NMR) is a reliable biomarker of CYP2A6 activity, our second and third approaches used additional genetic variants identified in genome-wide association studies of NMR to create a weighted genetic risk score (wGRS) to stratify smokers (fast vs. slow metabolizers) and calculate a wGRS-derived NMR.
Results: Controlling for race and sex, normal metabolizers (vs. reduced) selected a greater proportion of puffs from nicotine-containing cigarettes (vs. denicotinized) on the forced-choice task (p = .031). In confirmatory analyses, wGRS-based stratification (fast vs. slow metabolizers) produced similar findings. Additionally, wGRS-derived NMR, which correlated with actual NMR assessed in a subset of participants (n = 55), was positively associated with the proportion of puffs from nicotine-containing cigarettes controlling for race and sex (p = .015). None of the CYP2A6 indices were associated with tobacco cue-reactivity in minimally deprived smokers.
Conclusions: Findings suggest increased nicotine reinforcement is exhibited by smokers with high CYP2A6 activity, which may contribute to heavier smoking and poorer cessation outcomes previously reported in faster metabolizers.
Implications: CYP2A6 activity is a key determinant of smoking behavior and outcomes. Therefore, these findings support the targeting of CYP2A6 activity, either therapeutically or as a clinically relevant biomarker in a precision medicine approach, for tobacco use disorder treatment.

Item Type: Article
Depositing User: Kevin Butler
URI: https://sure.sunderland.ac.uk/id/eprint/14084

Further Details

More Information

Depositing User

Identifiers

Item ID
14084
Identification Number
ISSN
1469-994X

Users with ORCIDS

ORCID for Kevin Butler

Catalogue record

Date Deposited
04 Oct 2021 14:21
Last Modified
04 Jun 2025 15:51

Contributors

Author
M Chenoweth
Author
A El-Boraie
Author
H Giratallah
Author
W Kowalczyk
Author
S Heishman
Author
RF Tyndale
Author
B Le Foll

University Divisions

Subjects

Actions (login required)

View Item (Repository Staff Only)

Downloads per month over past year